Ofev 100 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F6U4Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,095
Award facts
- Contract value 100% obligated
- $9,094.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,094.99 for OFEV 100 mg capsules (60-count units) on December 10, 2025, with an ultimate completion date of January 2, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open procurement process. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering both brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for OFEV, a pharmaceutical treatment for idiopathic pulmonary fibrosis, reflects the company's role in supplying specialized medications to support military and federal healthcare operations. The DLA continues to leverage AmerisourceBergen's capabilities through flexible contract vehicles, with plans underway to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26F6U4Q?
SPE2DR26F6U4Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F6U4Q worth?
The government has obligated $9,095 on SPE2DR26F6U4Q.
Is contract SPE2DR26F6U4Q an order under another contract?
Yes. SPE2DR26F6U4Q is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6U4Q competed?
The extent of competition for SPE2DR26F6U4Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award